Elshad Hasanov

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial”.

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1003

N/A

0DataRank · unranked

17 citations

Yanting Zhang, Daniel J. McGrail, X. Zhang, Truong Lam, Anh Hoang +11 more

Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP)

Clinical Genitourinary Cancer(2024)10.1016/j.clgc.2024.102258

N/A

0DataRank · unranked

4 citations

Rajvi Goradia, Victor Heh, Akshay Sood, Matthew Lee, Young Son +6 more